Oxytocin is expressed throughout the human gastrointestinal tract

被引:70
作者
Ohlsson, Bodil
Truedsson, Mikael
Djerf, Pauline
Sundler, Frank
机构
[1] Lund Univ, Dept Clin Sci, Lund, Sweden
[2] Lund Univ, Dept Surg, Lund, Sweden
[3] Lund Univ, Dept Expt Med Sci, Div Neuroendocrine Cell Biol, Lund, Sweden
关键词
oxytocin; oxytocin receptor; immunohistochemistry; gastrointestinal tract;
D O I
10.1016/j.regpep.2006.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim: Several studies have described that oxytocin exerts stimulatory or inhibitory effects on gut functions. Recently, mRNA for oxytocin and its receptor was found throughout the entire human gastrointestinal (GI) tract. The aim of this study was to examine the cellular localization and distribution of the corresponding proteins. Material and methods: Full-thickness biopsies from 24 patients, covering the entire GI tract, were collected during operations at the Department of Surgery in Malmo and Lund. The biopsies were taken from non-affected margins. The biopsies were fixed by immersion, rinsed in buffered sucrose, and kept frozen at -70 degrees C. Indirect immunofluorescence with primary antibodies to oxytocin and its receptor was used. Results: Oxytocin was expressed in nerve cell bodies and nerve fibres in the myenteric and submucous ganglia all along the GI tract. Immunoreactive nerve cell bodies in myenteric ganglia predominated in the proximal (antrum and duodenum) and distal gut, while those in the submucous ganglia were more numerous in the ileum and colon. The oxytocin receptor was not detectable by two different antibodies in any tissue in the GI tract. Conclusion: Oxytocin is expressed in the myenteric and submucous ganglia and nerve fibres along the entire human GI tract. The role for oxytocin in the physiology and pathophysiology of the bowel remains to be settled. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 30 条
  • [21] Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats
    Petersson, M
    Alster, P
    Lundeberg, T
    UvnasMoberg, K
    [J]. NEUROSCIENCE LETTERS, 1996, 212 (02) : 87 - 90
  • [22] THE EFFECT OF OXYTOCIN ON BASAL AND PETHIDINE-INDUCED DELAYED GASTRIC-EMPTYING
    PETRING, OU
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (03) : 329 - 332
  • [23] Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin
    Stam, WB
    Van der Graaf, PH
    Saxena, PR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 865 - 873
  • [24] EFFECTS OF VASOPRESSIN AND OXYTOCIN ON CANINE CEREBRAL-CIRCULATION INVIVO
    SUZUKI, Y
    SATOH, S
    KIMURA, M
    OYAMA, H
    ASANO, T
    SHIBUYA, M
    SUGITA, K
    [J]. JOURNAL OF NEUROSURGERY, 1992, 77 (03) : 424 - 431
  • [25] Human vascular endothelial cells express oxytocin receptors
    Thibonnier, M
    Conarty, DM
    Preston, JA
    Plesnicher, CL
    Dweik, RA
    Erzurum, SC
    [J]. ENDOCRINOLOGY, 1999, 140 (03) : 1301 - 1309
  • [26] OXYTOCIN INCREASES AND A SPECIFIC OXYTOCIN ANTAGONIST DECREASES PAIN THRESHOLD IN MALE-RATS
    UVNASMOBERG, K
    BRUZELIUS, G
    ALSTER, P
    BILEVICIUTE, I
    LUNDEBERG, T
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 144 (04): : 487 - 488
  • [27] Interstitial cells of Cajal in enteric neurotransmission
    Ward, SM
    [J]. GUT, 2000, 47 : 40 - 43
  • [28] The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas
    Wierup, N
    Svensson, H
    Mulder, H
    Sundler, F
    [J]. REGULATORY PEPTIDES, 2002, 107 (1-3) : 63 - 69
  • [29] Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats
    Wu, CL
    Hung, CR
    Chang, FY
    Pau, KYF
    Wang, PS
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (04) : 406 - 413
  • [30] Modulation by oxytocin of ATP-activated currents in rat dorsal root ganglion neurons
    Yang, Q
    Wu, ZZ
    Li, X
    Li, ZW
    Wei, JB
    Hu, QS
    [J]. NEUROPHARMACOLOGY, 2002, 43 (05) : 910 - 916